← Explore

Auricular Ultrasonic Vagus Nerve Stimulation: Effectiveness of Blinding and Occurrence of Adverse Effects in Healthy Volunteers

Bas Labree, Marcus Kaiser, Mohamad A. Pourhoseingholi, Derek J. Hoare, Magdalena Sereda

Brain Sciences 2025 · 10.3390/brainsci15090986

human healthyhealthynone reported

Abstract

Background/objectives Both invasive and non-invasive electrical stimulation of the vagus nerve have been studied as potential treatments for neurological conditions, with mixed results. Ultrasonic Vagus Nerve Stimulation (U-VNS), which non-invasively stimulates the auricular branch of the vagus nerve using ultrasound, may offer a more targeted and effective approach than electric currents. To facilitate future clinical trials of U-VNS, this study aimed to (1) investigate the effectiveness of blinding of a U-VNS device versus a sham device and (2) record the type, onset, and duration of any adverse effects resulting from U-VNS. Methods In this single-blind randomised controlled study, twenty healthy volunteers were randomly assigned to receive either a 30 min session of true U-VNS and a 30 min session of sham stimulation 1 week later, or vice versa. The effectiveness of blinding and the occurrence of adverse effects were measured using self-report questionnaires. Results James' Blinding Index showed that blinding using the sham device was highly effective in both the real U-VNS condition, BI = 0.9 (95% CI: 0.7-1.0), and the sham condition, BI = 1.0 (95% CI: 1.0-1.0). The adverse effects reported were mild, transient, and mostly related to sensations on the skin immediately under the transducer of the device. Conclusions A high level of blinding effectiveness can be achieved for U-VNS by using a sham device. Adverse effects are generally mild and transient. These findings will inform the design of future clinical trials of U-VNS.

Abstract via europepmc.

Specieshuman
Subjects20 participants
Sessions per subject1
Randomisedyes
Blindingsingle
Sham / controlinactive transducer
Auditory controlmatched device sound
Readout timingnot reported
Anaesthesianot applicable
Readoutsnone reported
Direction of effectnot assessedThis study assessed blinding effectiveness and adverse effects only; no neuromodulatory or physiological effect of stimulation was assessed.
Adverse eventsobservedAdverse effects reported by participants were generally uncommon, mild, and transient, mostly sensations (itching, burning, pain, tingling, warmth) on the skin under the transducer; four participants reported effects persisting past the session (one 5-10 min, one 'shortly', one 'briefly', one 30 min of painful skin).

Exposures

Exposure 1: Real ultrasonic vagus nerve stimulation (U-VNS) via ZenBud device

Target: vagus nerve — “auricular branch of the vagus nerve
Device: other named manufacturer · NeurGear · ZenBud

Pulse timing
Waveformpulsed
Fundamental frequency (kHz)5,300✓✓
Pulse duration (ms)not reportedimplied by duty cycle ÷ PRF: 12.1951 ms (not stated by the paper)
Pulse repetition frequency (Hz)41✓✓
Duty cycle (%)50✓✓
Sonication duration (s)1,740✓✓
Pressure and intensity, by domain
Free-field pressure (kPa)not reported
Free-field Isppa (W/cm²)not reported
Free-field Ispta (W/cm²)not reported
In-situ estimatenot reported
In-situ pressure (kPa)not reported
In-situ Isppa (W/cm²)not reported
In-situ Ispta (W/cm²)not reported
Pressure, domain unspecified (kPa)1,030✓✓
Protocol, in the paper’s words

It delivers low-intensity focused ultrasound to the auricular branch of the vagus nerve through several layers of skin (centre frequency 5.3 MHz, pulse repetition rate 41 hertz, 50% duty cycle, average intensity of 1.03 MPa). As a safety measure, the device shuts down automatically after running for 29 min. Participants sat in a quiet room with an investigator whilst undergoing stimulation (or sham) using the ZenBud device for 29 min; the abstract describes this as a '30 min session'.

Flags from extraction

  • exposures[0].unspecified_domain.pressure_kpaThe paper labels this value 'average intensity of 1.03 MPa', but MPa is a pressure unit not an intensity unit; recorded as a pressure (1030 kPa) since the stated units are MPa. Domain (free-field vs in-situ) is not specified by the paper, so placed in unspecified_domain.
  • exposures[0].timing.sonication_duration_sAbstract states sessions were '30 min', but the Methods/Procedure and device description both state the device runs for 29 min and auto-shuts-off after 29 min; 29 min (1740 s) used as the more specific/detailed value, with the discrepancy flagged.
  • exposures[0].timing.pulse_duration_msPRF (41 Hz) and duty cycle (50%) are both stated, which could allow pulse duration to be computed, but the paper does not state pulse duration directly, so left not_reported per the no-arithmetic rule.
  • readoutsThis study assessed only blinding effectiveness and adverse effects via questionnaires, not a physiological or behavioural effect of stimulation, hence classified as none_reported.